Kiniksa Pharmaceuticals International
KNSA | NASDAQ
$78.72
+$0.59 (+0.76%)
Sep 22, 2026, 1:02 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 25.43M | 22.59M | -88M | 18.44M | 17.83M | 8.54M | -8.89M | -12.69M | -3.91M | -17.7M | 25.24M | -13.86M | 14.97M | -12.27M | 4.46M | 224.09M | -19.98M | -25.21M | -36.33M | -30.54M | -41.56M | -49.48M |
Depreciation & Amortization | 565K | 1.77M | 339K | 384K | 358K | 345K | 400K | 399K | 430K | 466K | 236K | 603K | 602K | 596K | 602K | 493K | 651K | 656K | 668K | 658K | 717K | 312K |
Stock-Based Compensation | 11.64M | 10.06M | 3.93M | 10.14M | 8.88M | 7.75M | 8.3M | 7.83M | 7.36M | 7.21M | 7.77M | 6.79M | 6.47M | 6.12M | 6.37M | 6.04M | 6.68M | 6.03M | 6.13M | 6.2M | 5.72M | 7.13M |
Other Working Capital | n/a | 13.93M | 7.35M | 14.76M | 9.36M | -4.42M | 41.34M | 2.95M | 397K | 2.13M | 12.57M | -9.33M | 12.54M | 3.36M | -14.25M | 15.74M | -10.1M | 14.27M | 8.26M | -3.1M | 913K | 839K |
Other Non-Cash Items | 17.22M | 940K | 119.93M | 1.5M | 46K | 1.1M | 1.59M | 267K | 624K | 1.08M | 749K | 2.15M | -383K | -45K | 595K | 642K | 856K | 899K | 886K | 716K | 793K | 1M |
Deferred Income Tax | 2.66M | 4.52M | -1.73M | 4.23M | 2.64M | 2.99M | -3.16M | -3.64M | 10.57M | 4.37M | -25.71M | 10.29M | -19.44M | 1.08M | 348K | -185.84M | n/a | n/a | 11K | n/a | -10K | 10K |
Change in Working Capital | -10.05M | 10.32M | 19.43M | -1.02M | -1.67M | 1.6M | 20.54M | 5.6M | -9.91M | 8.58M | -3.96M | 11.01M | -5.96M | 260K | -23.95M | 16.63M | 3.97M | -19.22M | 9.75M | -5.54M | -4.44M | 911K |
Operating Cash Flow | 47.46M | 50.2M | 53.89M | 33.68M | 28.09M | 22.32M | 18.77M | -2.24M | 5.17M | 3.99M | 4.33M | 16.99M | -3.74M | -4.27M | -11.58M | 62.05M | -7.82M | -36.85M | -18.88M | -28.51M | -38.78M | -40.12M |
Capital Expenditures | -663K | -161K | -633K | -671K | -165K | -99K | -193K | n/a | n/a | -84K | -56K | -16K | -34K | -24K | 32K | -22K | -115K | n/a | -251K | -51K | -59K | -20.05M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25K | n/a | n/a | 14.84M | 12.26M | -35.57M | 37.9M | 10K | n/a | 91K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -109.62M | -177.41M | 73.94M | -146.16M | -34.32M | -95.47M | -21.99M | -54.48M | -89.26M | -36.28M | -60.82M | -53.09M | -38.13M | -52.9M | -62.8M | -17.33M | -25.51M | -30.22M | -59.79M | n/a | -23.1M | -74.36M |
Sales Maturities Of Investments | 36.7M | 145.66M | 81.23M | 84.08M | 30.61M | 44.03M | 87.48M | 48.13M | 42.44M | 61.88M | 45.98M | 40.83M | 73.7M | 15M | 20.1M | 36.4M | 63.8M | 7.5M | 10M | 47.9M | 109.15M | 139.25M |
Other Investing Acitivies | n/a | n/a | -226.64M | n/a | n/a | n/a | n/a | 25K | 25K | n/a | -14.84M | -12.26M | 35.57M | -37.9M | n/a | -10K | n/a | n/a | n/a | n/a | n/a | -20M |
Investing Cash Flow | -73.58M | -31.92M | -70.81M | -62.76M | -3.88M | -51.54M | 65.29M | -6.35M | -46.8M | 25.52M | -14.89M | -12.28M | 35.53M | -37.92M | -42.66M | 19.04M | 38.27M | -22.72M | -50.04M | 47.85M | 85.99M | 44.83M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 316K | -316K | -918K | -4.35M | -2.05M | -412K | -578K | -2.71M | -1.31M | -381K | -262K | -1.11M | -419K | -420K | -100K | -208K | -24K | -569K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 12.11M | n/a | 8.58M | 16.25M | 12.75M | 3.18M | 2.72M | 9.4M | 1.14M | 3.99M | 957K | 1.66M | 577K | 510K | n/a | 569K | 566K | 992K | n/a | n/a | n/a | n/a |
Financial Cash Flow | 6.04M | 6.07M | 7.66M | 11.9M | 10.7M | 2.77M | 2.14M | 6.69M | -178K | 3.61M | 695K | 552K | 158K | 90K | 1.19M | 361K | 542K | 423K | 1.21M | 2.68M | 887K | 1.11M |
Net Cash Flow | -20.08M | 24.36M | -9.26M | -17.18M | 34.91M | -26.45M | 86.21M | -1.9M | -41.81M | 33.12M | -9.87M | 5.26M | 31.95M | -42.1M | -53.05M | 81.45M | 30.98M | -59.15M | -67.71M | 22.02M | 48.1M | 5.82M |
Free Cash Flow | 46.8M | 50.04M | 53.26M | 33.01M | 27.93M | 22.23M | 18.58M | -2.24M | 5.17M | 3.9M | 4.27M | 16.97M | -3.78M | -4.29M | -11.54M | 62.03M | -7.94M | -36.85M | -19.14M | -28.56M | -38.84M | -60.18M |
Adj. Free Cash Flow | 35.16M | 39.98M | 49.34M | 22.86M | 19.05M | 14.48M | 10.28M | -10.06M | -2.2M | -3.3M | -3.5M | 10.18M | -10.25M | -10.41M | -17.92M | 55.99M | -14.62M | -42.88M | -25.27M | -34.76M | -44.56M | -67.3M |
Maintenance CapEx | -565K | -161K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16K | n/a | n/a | 64K | n/a | n/a | n/a | n/a | n/a | n/a | -20.05M |
Growth CapEx | -98K | n/a | -633K | -671K | -165K | -99K | -193K | n/a | n/a | -84K | -56K | n/a | -34K | -24K | -32K | -22K | -115K | n/a | -251K | -51K | -59K | n/a |
Owner Earnings | 46.89M | 50.04M | 53.89M | 33.68M | 28.09M | 22.32M | 18.77M | -2.24M | 5.17M | 3.99M | 4.33M | 16.97M | -3.74M | -4.27M | -11.51M | 62.05M | -7.82M | -36.85M | -18.88M | -28.51M | -38.78M | -60.18M |
Add to Watchlist
Select watchlists to add or remove KNSA